規格 | 目錄價格 | 上海 | 安徽 | 武漢 | 成都 | 北方 | 深圳 | 會員價格 | 數量 |
---|---|---|---|---|---|---|---|---|---|
1g | ¥ ????? | > 10 | -- | -- | -- | -- | -- | ¥ ????? | - + |
5g | ¥ ????? | > 10 | -- | 1 | -- | 1 | 1 | ¥ ????? | - + |
10g | ¥ ?????? | > 10 | -- | -- | -- | 1 | -- | ¥ ?????? | - + |
25g | ¥ ?????? | > 10 | -- | 1 | -- | -- | -- | ¥ ?????? | - + |
100g | ¥ ??????? | 8 | -- | -- | -- | -- | -- | ¥ ??????? | - + |
500g | ¥ ??????? | 1 | -- | -- | -- | -- | -- | ¥ ??????? | - + |
1000g | 請詢價 | -- | -- | -- | -- | -- | -- | -- | - + |
大貨 | 請詢價 | -- | -- | -- | -- | -- | -- | -- | - + |
產品編號
1034215
CAS 號
51298-62-5
中文名稱
Nω-硝基-L-精氨酸甲酯鹽酸鹽
MDL 號
MFCD00039052
分子量
269.69
存儲條件
-20°C, sealed storage, away from moisture
網頁展示純度為入庫指導純度值,各批次間存在一定差異,實際純度以收貨為準
熔點
157-161°C
沸點
383.5°C at 760 mmHg
閃點
185.8°C
旋光
描述
TPSA
143.37
LogP
-1.00563
H_Acceptors
6
H_Donors
4
Rotatable_Bonds
6
[1]. Kopincová J, et al. L-NAME in the cardiovascular system - nitric oxide synthase activator? Pharmacol Rep. 2012;64(3):511-20.
[2]. Lo HC, et al. The Nitric Oxide Synthase Inhibitor NG-Nitro-L-Arginine Methyl Ester Diminishes the Immunomodulatory Effects of Parental Arginine in Rats with Subacute Peritonitis. PLoSOne. 2016 Mar 23;11(3):e0151973.
[3]. Luo H, et al. Effect of nitric oxide synthase inhibitor L-NAME on fear extinction in rats: a task-dependent effect. Neurosci Lett. 2014 Jun 20;572:13-8.
[4]. Ocsan RJ, et al. Chronic NG-nitro-l-arginine methyl ester (L-NAME) administration in C57BL/6J mice induces a sustained decrease in c-kit positive cells during development of cardiac hypertrophy. J Physiol Pharmacol. 2013 Dec;64(6):727-36.
[5]. Pfeiffer S, et al. Inhibition of nitric oxide synthesis by NG-nitro-L-arginine methyl ester (L-NAME): requirement forbioactivation to the free acid, NG-nitro-L-arginine. Br J Pharmacol. 1996 Jul;118(6):1433-40.
警示圖
警示詞
Warning
危險申明
H302-H315-H319-H335
警告申明
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
GHS 編碼
GHS07
現貨供應
專業護航
售后無憂
品質保障
無需湊單